Yixintang Pharmaceutical Group Co Ltd
SZSE:002727
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
11.09
26.22
|
Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Gross Margin
Yixintang Pharmaceutical Group Co Ltd
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Gross Margin Across Competitors
Country | CN |
Market Cap | 8.1B CNY |
Gross Margin |
31%
|
Country | ZA |
Market Cap | 98.2B Zac |
Gross Margin |
23%
|
Country | ZA |
Market Cap | 31.9B Zac |
Gross Margin |
23%
|
Country | BR |
Market Cap | 44.6B BRL |
Gross Margin |
30%
|
Country | US |
Market Cap | 7.5B USD |
Gross Margin |
18%
|
Country | JP |
Market Cap | 845.2B JPY |
Gross Margin |
35%
|
Country | SA |
Market Cap | 16.8B SAR |
Gross Margin |
39%
|
Country | CN |
Market Cap | 27.3B CNY |
Gross Margin |
38%
|
Country | MX |
Market Cap | 70.6B MXN |
Gross Margin |
23%
|
Country | JP |
Market Cap | 547.7B JPY |
Gross Margin |
20%
|
Country | NL |
Market Cap | 2.9B EUR |
Gross Margin |
23%
|
Yixintang Pharmaceutical Group Co Ltd
Glance View
Yixintang Pharmaceutical Group Co., Ltd. engages in the pharmaceutical retail chain and pharmaceutical wholesale business. The company is headquartered in Kunming, Yunnan and currently employs 32,503 full-time employees. The company went IPO on 2014-07-02. The Company’s main products include traditional Chinese medicines, western medicines, medical equipment, birth control products and disinfection products, among others. The firm distributes its products through regular chain drugstores. The firm mainly operates its business in domestic market, with southwest area of China as its main market.
See Also
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Based on Yixintang Pharmaceutical Group Co Ltd's most recent financial statements, the company has Gross Margin of 31.5%.